Back to top

Vaxart (VXRT) Reports Safety Data from Phase 2b COVID-19 Vaccine Trial

Vaxart (VXRT) Reports Safety Data from Phase 2b COVID-19 Vaccine Trial

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

VAXART, INC. (VXRT)